Sign in
Not yet recruitingPhase 4

Incidence and severity of postoperative delirium associated with Dexmedetomidine sedation during femur osteosynthesis in the elderly population

Key facts

Who runs it
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Where
Spain1 site in 1 countryChoose a country to see its sites
Status
Not yet recruiting
Phase
Phase 4
People taking part
80 people, planned
Started
1 Sept 2026
Expected to end
1 Sept 2027
Type of study
Interventional
Record updated
31 August 2026

Who can take part

Age
65 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Age 75 or older
  • Patients underwent surgery for a femur fracture under intradural anesthesia with sedation
  • It should be performed on a deferred emergency basis (within 48–72 hours)

Who cannot take part

  • Known allergy to dexmedetomidine or propofol, or a contraindication to their use
  • Presence of severe psychiatric or cognitive disorders
  • Patient refusal or lack of cooperation in the study
  • Participation in other studies that could interfere with the conduct of this study

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To assess the severity and progression of delirium in the postoperative period following femur fracture surgery in patients over 75 years of age who received intradural anesthesia combined with dexmedetomidine sedation, and to compare these findings with those from the use of propofol.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Record updated
31 August 2026